v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Assets    
Cash $ 25,745
Prepaid expenses 163,017
Deferred offering costs associated with initial public offering 131,602
Total current assets 188,762 131,602
Marketable securities held in trust account 89,339,290
Total Assets 89,528,052 131,602
Liabilities, Ordinary Shares subject to possible redemption, and Shareholders’ (Deficit) Equity    
Accounts payable and accrued expenses 2,268,470 3,124
Total current liabilities 2,268,470 114,314
Deferred underwriting fee 3,450,000
Sponsor loan payable 500,000
Total non-current liabilities 3,950,000
Total Liabilities 6,218,470 114,314
Commitment and Contingencies (Note 7)
Shareholders’ (Deficit) Equity    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 24,698
Accumulated deficit (6,030,037) (7,712)
Total Shareholders’ (Deficit) Equity (6,029,708) 17,288
Total Liabilities, Ordinary Shares subject to possible redemption, and Shareholders’ (Deficit) Equity 89,528,052 131,602
Related Party    
Liabilities, Ordinary Shares subject to possible redemption, and Shareholders’ (Deficit) Equity    
Due to related party 111,190
Class A Ordinary Shares    
Temporary equity – Class A ordinary shares subject to possible redemption    
Class A ordinary shares, $0.0001 par value; 8,625,000 shares subject to possible redemption at $10.36 per share as of December 31, 2025 (zero as of December 31, 2024) 89,339,290
Shareholders’ (Deficit) Equity    
Ordinary shares, value 230
Class B Ordinary Shares    
Shareholders’ (Deficit) Equity    
Ordinary shares, value [1] $ 99 $ 302
[1] Includes up to 393,750 Class B ordinary shares that were subject to forfeiture until the over-allotment option was exercised in full by the underwriters (Note 6).